More recently, a role for CCL8 has been proposed for the development of acute respiratory distress syndrome (ARDS) after SARS‐CoV‐2 infection, while the beneficial effects of CCL8 inhibition have been described following lipopolysaccharide administration in mice [16, 17, 18, 19]. Here, CCL8 is linked to acute respiratory distress syndrome.